Publication: Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2.
Loading...
Identifiers
Date
2021-01-29
Authors
Miro, Oscar
Llorens, Pere
Jimenez, Sonia
Piñera, Pascual
Burillo-Putze, Guillermo
Martin, Alfonso
Martin-Sanchez, Francisco Javier
Gonzalez-Del-Castillo, Juan
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Abstract
Infection by SARS-CoV-2 is mainly characterized by fever and respiratory symptoms, with dyspnea and lung infiltrates in more severe cases. Many patients also present a pro-coagulant state, which is biochemically detected by increased D-dimer levels and is related to complications and a worse prognosis. In this context, isolated case reports and short case series have suggested an increased risk of patients with COVID-19 developing clinically relevant cardiovascular and hemostatic disturbances. Nonetheless, many of these reports refer to hospitalized patients, and as hospitalization itself usually increases complications in bedridden patients with multidrug treatment or in very poor condition, it is unknown if such cardiovascular/hemostatic processes are related to the pathogenesis of SARS-CoV-2. Focusing on patients with COVID-19 at emergency department (ED) arrival could help answer this question.
Description
MeSH Terms
Acute Coronary Syndrome
Aged
Aged, 80 and over
COVID-19
Cardiovascular Diseases
Case-Control Studies
Female
Gastrointestinal Hemorrhage
Hemostasis
Humans
Male
Middle Aged
Aged
Aged, 80 and over
COVID-19
Cardiovascular Diseases
Case-Control Studies
Female
Gastrointestinal Hemorrhage
Hemostasis
Humans
Male
Middle Aged
DeCS Terms
Hemostáticos
Infecciones
Disnea
Fiebre
Coagulantes
Servicio de Urgencia en Hospital
Infecciones
Disnea
Fiebre
Coagulantes
Servicio de Urgencia en Hospital
CIE Terms
Keywords
Área Sanitaria Norte de Córdoba, Pulmonary Embolism, Retrospective Studies, Stroke, Venous Thrombosis
Citation
Miró Ò, Llorens P, Jiménez S, Piñera P, Burillo-Putze G, Martín A, et al. Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2. Int J Cardiol. 2021 May 1;330:268-272